Dr. Marie-Laure Yaspo
Co-founder and Chief Scientific Officer
Dr. Weilin Liu, with a Ph.D. in Molecular Medicine from the University of Groningen, has been a beacon in the realm of metabolic diseases and oncology. His prominent research on Fibroblast factor 1 (FGF1) was showcased in esteemed journals like PNAS and Nature. At Groningen, he delved deep into metabolic homeostasis, revealing novel insights on prevalent diseases. Mentored by renowned figures like Dr. Johan W. Jonker, his findings have garnered national media attention. Beyond his core research, Dr. Liu's tenure at Wageningen University & Research and a stint at Duke University underscore his diverse expertise. He remains a stalwart in molecular biology, ever eager to further the frontiers of science.